Supplementary Table S1 from Lactate Induces Tumor Progression Via LAR Motif-Dependent Yin-Yang 1 Degradation

Shujuan Du,Xiaoting Chen,Xiao Han,Yuyan Wang,Dan Yu,Ying Li,Caixia Zhu,Yin Tong,Shujun Gao,Junwen Wang,Fang Wei,Qiliang Cai

DOI: https://doi.org/10.1158/1541-7786.27150983

2024-01-01

Abstract:Supplementary Table S1. Oligonucleotides.

What problem does this paper attempt to address?

Supplementary Table S2 from Lactate Induces Tumor Progression Via LAR Motif-Dependent Yin-Yang 1 Degradation

Shujuan Du,Xiaoting Chen,Xiao Han,Yuyan Wang,Dan Yu,Ying Li,Caixia Zhu,Yin Tong,Shujun Gao,Junwen Wang,Fang Wei,Qiliang Cai

DOI: https://doi.org/10.1158/1541-7786.27150977

2024-01-01

Abstract:Supplementary Table S2. Hit-region sequences
Supplementary Tables from LIMS1 Promotes Pancreatic Cancer Cell Survival under Oxygen–Glucose Deprivation Conditions by Enhancing HIF1A Protein Translation

Chongbiao Huang,Yang Li,Zengxun Li,Yang Xu,Na Li,Yi Ge,Jie Dong,Antao Chang,Tiansuo Zhao,Xiuchao Wang,Hongwei Wang,Shengyu Yang,Keping Xie,Jihui Hao,He Ren

DOI: https://doi.org/10.1158/1078-0432.22470555

2023-01-01

Abstract:7 Supplementary Tables: Supplementary Table S1. Association between LIMS1 expression and clinicopathological features of patients with PDAC. Supplementary Table S2. Association between LIMS1 mRNA expression and clinicopathological features of PDAC patients from TCGA. Supplementary Table S3. Cox's proportional hazards model analysis of prognostic factors in patients with pancreatic ductal adenocarcinoma (PDAC) Supplementary Table S4. Association between LIMS1 expression and clinicopathological features of patients with esophageal cancer. Supplementary Table S5. Association between LIMS1 expression and clinicopathological features of patients with lung adenocarcinoma. Supplementary Table S6. Main antibodies and reagents. Supplementary Table S7. Primers and oligonucleotides sequences.
Supplementary Figure S5 from Lactate Induces Tumor Progression Via LAR Motif-Dependent Yin-Yang 1 Degradation

Shujuan Du,Xiaoting Chen,Xiao Han,Yuyan Wang,Dan Yu,Ying Li,Caixia Zhu,Yin Tong,Shujun Gao,Junwen Wang,Fang Wei,Qiliang Cai

DOI: https://doi.org/10.1158/1541-7786.27150989

2024-01-01

Abstract:S5. LA dramatically enhances malignancy of cancer cells with low expression of YY1.
Supplementary Figure S6 from Lactate Induces Tumor Progression Via LAR Motif-Dependent Yin-Yang 1 Degradation

Shujuan Du,Xiaoting Chen,Xiao Han,Yuyan Wang,Dan Yu,Ying Li,Caixia Zhu,Yin Tong,Shujun Gao,Junwen Wang,Fang Wei,Qiliang Cai

DOI: https://doi.org/10.1158/1541-7786.27150986

2024-01-01

Abstract:S6. Brief schematic of lactate-induced YY1 degradation via chaperone-mediated autophagy for tumor growth and malignancy.
Supplementary Figure S2 from Lactate Induces Tumor Progression Via LAR Motif-Dependent Yin-Yang 1 Degradation

Shujuan Du,Xiaoting Chen,Xiao Han,Yuyan Wang,Dan Yu,Ying Li,Caixia Zhu,Yin Tong,Shujun Gao,Junwen Wang,Fang Wei,Qiliang Cai

DOI: https://doi.org/10.1158/1541-7786.27150998

2024-01-01

Abstract:S2. Distribution of WT YY1 and its mutants in the presence or absence of LA.
Supplementary Table S1 from Distinct Regulation of ASCL1 by the Cell Cycle and Chemotherapy in Small Cell Lung Cancer

Yuning Liu,Qingzhe Wu,Bin Jiang,Tingting Hou,Chuanqiang Wu,Ming Wu,Hai Song

DOI: https://doi.org/10.1158/1541-7786.26144994

2024-01-01

Abstract:Supplementary Table S1. Sequences for sgRNA, shRNA or siRNA.
Supplementary Table 2 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Lauren Averett Byers,Jing Wang,Monique B. Nilsson,Junya Fujimoto,Pierre Saintigny,John Yordy,Uma Giri,Michael Peyton,You Hong Fan,Lixia Diao,Fatemeh Masrorpour,Li Shen,Wenbin Liu,Boris Duchemann,Praveen Tumula,Vikas Bhardwaj,James Welsh,Stephanie Weber,Bonnie S. Glisson,Neda Kalhor,Ignacio I. Wistuba,Luc Girard,Scott M. Lippman,Gordon B. Mills,Kevin R. Coombes,John N. Weinstein,John D. Minna,John V. Heymach

DOI: https://doi.org/10.1158/2159-8290.22528425

2023-01-01

Abstract:PDF file, 64K, Non-small cell lung cancer cell lines.
Additional File 9 of Carbohydrates and Ginsenosides in Shenmai Injection Jointly Improve Hematopoietic Function During Chemotherapy-Induced Myelosuppression in Mice

Shiyu Zhang,Tingting Ye,Li Liu,Xiaohui Fan,Xiaoyan Lu,Jing Qian

DOI: https://doi.org/10.6084/m9.figshare.21507439

2022-01-01

Abstract:Additional file 9: Table S6. GO analysis of common DEGs in S and S+Rg groups.
Lactate induces tumor progression via LAR motif-dependent Yin-Yang 1 degradation

Shujuan Du,Xiaoting Chen,Xiao Han,Yuyan Wang,Dan Yu,Ying Li,Caixia Zhu,Yin Tong,Shujun Gao,Junwen Wang,Fang Wei,Qiliang Cai

DOI: https://doi.org/10.1158/1541-7786.mcr-23-0583

2024-06-19

Molecular Cancer Research

Abstract:Metabolic reprogramming of aerobic glycolysis contributes to tumorigenesis. High plasma lactate is a critical regulator in the development of many human malignancies; however, the underlying molecular mechanisms of cancer progression in the response to lactate (LA) remain elusive. Here we show that reduction of Yin-Yang 1 (YY1) expression correlated with high LA commonly occurs in various cancer cell types, including B-lymphoma and cervical cancer. Mechanistically, LA induces YY1 nuclear export and degradation via HSP70-mediated autophagy adjacent to mitochondria in a Histidine-rich LAR (LA-responsive) motif-dependent manner. Mutation of the LAR motif blocks LA-mediated YY1 cytoplasmic accumulation and in turn enhances cell apoptosis. Furthermore, low expression of YY1 promotes the colony formation, invasion, angiogenesis and growth of cancer cells in response to LA in vitro and in vivo using a murine xenograft model. Taken together, our findings reveal that a key lactate-responsive` element and may serve as therapeutic target for intervening cancer progression. Implications: We have shown lactate can induce YY1 degradation via its Histidine-rich LAR motif, and low expression of YY1 promotes cancer cell progression in response to lactate, leading to better prediction of YY1-targeting therapy.

oncology,cell biology
Supplementary Table 1 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis

Alfred S.L. Cheng,Suki S. Lau,Yangchao Chen,Yutaka Kondo,May S. Li,Hai Feng,Arthur K. Ching,Kin F. Cheung,Hoi K. Wong,Joanna H. Tong,Hongchuan Jin,Kwong W. Choy,Jun Yu,Ka F. To,Nathalie Wong,Tim H.-M. Huang,Joseph J.Y. Sung

DOI: https://doi.org/10.1158/0008-5472.22395236.v1

2023-01-01

Abstract:Supplementary Table 1 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis
Supplemental Table S3 from Histone Deacetylase HDAC8 Promotes Insulin Resistance and Β-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma

Yuan Tian,Vincent W.S. Wong,Grace L.H. Wong,Weiqin Yang,Hanyong Sun,Jiayun Shen,Joanna H.M. Tong,Minnie Y.Y. Go,Yue S. Cheung,Paul B.S. Lai,Mingyan Zhou,Gang Xu,Tim H.M. Huang,Jun Yu,Ka F. To,Alfred S.L. Cheng,Henry L.Y. Chan

DOI: https://doi.org/10.1158/0008-5472.22412055.v1

2023-01-01

Abstract:The primers used in this study.
Supplementary Methods, Figures 1-9, Tables 2-6 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes Β-Catenin–dependent Hepatocarcinogenesis

Alfred S.L. Cheng,Suki S. Lau,Yangchao Chen,Yutaka Kondo,May S. Li,Hai Feng,Arthur K. Ching,Kin F. Cheung,Hoi K. Wong,Joanna H. Tong,Hongchuan Jin,Kwong W. Choy,Jun Yu,Ka F. To,Nathalie Wong,Tim H.-M. Huang,Joseph J.Y. Sung

DOI: https://doi.org/10.1158/0008-5472.22395239.v1

2023-01-01

Abstract:Supplementary Methods, Figures 1-9, Tables 2-6 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis
Supplementary Table 7 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes Β-Catenin–dependent Hepatocarcinogenesis

Alfred S.L. Cheng,Suki S. Lau,Yangchao Chen,Yutaka Kondo,May S. Li,Hai Feng,Arthur K. Ching,Kin F. Cheung,Hoi K. Wong,Joanna H. Tong,Hongchuan Jin,Kwong W. Choy,Jun Yu,Ka F. To,Nathalie Wong,Tim H.-M. Huang,Joseph J.Y. Sung

DOI: https://doi.org/10.1158/0008-5472.22395233

2023-01-01

Abstract:Supplementary Table 7 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis
Supplementary Table 1 from RAGE Expression in Tumor-Associated Macrophages Promotes Angiogenesis in Glioma

Xuebo Chen,Leying Zhang,Ian Y. Zhang,Junling Liang,Huaqing Wang,Mao Ouyang,Shihua Wu,Anna Carolina Carvalho da Fonseca,Lihong Weng,Yasuhiko Yamamoto,Hiroshi Yamamoto,Rama Natarajan,Behnam Badie

DOI: https://doi.org/10.1158/0008-5472.22402854

2023-01-01

Abstract:Supplementary Table 1: Primers used in the real-time quantitative PCR.
Table S1 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Binghao Li,Zhan Wang,Hao Wu,Mingfeng Xue,Peng Lin,Shengdong Wang,Nong Lin,Xin Huang,Weibo Pan,Meng Liu,Xiaobo Yan,Hao Qu,Lingling Sun,Hengyuan Li,Yan Wu,Wangsiyuan Teng,Zenan Wang,Xingzhi Zhou,Huabiao Chen,Mark C. Poznansky,Zhaoming Ye

DOI: https://doi.org/10.1158/0008-5472.22419831

2023-01-01

Abstract:Supplementary Table S1. Primers for qRT-PCR and MSP
Supplemental Table S1 from Histone Deacetylase HDAC8 Promotes Insulin Resistance and Β-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma

Yuan Tian,Vincent W.S. Wong,Grace L.H. Wong,Weiqin Yang,Hanyong Sun,Jiayun Shen,Joanna H.M. Tong,Minnie Y.Y. Go,Yue S. Cheung,Paul B.S. Lai,Mingyan Zhou,Gang Xu,Tim H.M. Huang,Jun Yu,Ka F. To,Alfred S.L. Cheng,Henry L.Y. Chan

DOI: https://doi.org/10.1158/0008-5472.22412061

2023-01-01

Abstract:Targeted gene expression profiling of 115 chromatin regulators in murine obesity-promoted HCC models.
Table S2 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Binghao Li,Zhan Wang,Hao Wu,Mingfeng Xue,Peng Lin,Shengdong Wang,Nong Lin,Xin Huang,Weibo Pan,Meng Liu,Xiaobo Yan,Hao Qu,Lingling Sun,Hengyuan Li,Yan Wu,Wangsiyuan Teng,Zenan Wang,Xingzhi Zhou,Huabiao Chen,Mark C. Poznansky,Zhaoming Ye

DOI: https://doi.org/10.1158/0008-5472.22419828

2023-01-01

Abstract:Supplementary Table S2. Patient characteristics
Supplementary Table 1 from CD155T/TIGIT Signaling Regulates CD8+ T-cell Metabolism and Promotes Tumor Progression in Human Gastric Cancer

Weiling He,Hui Zhang,Fang Han,Xinlin Chen,Run Lin,Wei Wang,Haibo Qiu,Zhuang Zhang,Ling Qi,Weijing Zhang,Qinbo Cai,Yongmei Cui,Wenting Jiang,Han Wang,Zunfu Ke

DOI: https://doi.org/10.1158/0008-5472.22415936.v1

2023-01-01

Abstract:Supplementary Table 1 shows clinicopathological characteristics of the patients studies in this project.
Supplementary Tables from MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway

Tao Yu,Yingjun Zhao,Zhixiang Hu,Jing Li,Dandan Chu,Jiwei Zhang,Zhe Li,Bing Chen,Xiao Zhang,Hongyu Pan,Shengli Li,Hechun Lin,Lei Liu,Mingxia Yan,Xianghuo He,Ming Yao

DOI: https://doi.org/10.1158/0008-5472.22418429.v1

2023-01-01

Abstract:Several tables contain the nucleotide sequences, antibodies information, LncRNA expression profiles, LncRNA screening, the correlation between MetaLnc9 and clinicopathological features, the mass spectrometric analysis results, RNA-seq analysis, KEGG and GSEA analysis.
Supplementary Table 6 from linc00869 Promotes Hepatocellular Carcinoma Metastasis Via Protrusion Formation

Xiaowen Shao,Yamei Dang,Tingting Zhang,Nan Bai,Jianing Huang,Mengya Guo,Li Sun,Minghe Li,Xiao Sun,Xinran Zhang,Feng Han,Ning Zhang,Hao Zhuang,Yongmei Li

DOI: https://doi.org/10.1158/1541-7786.25325105

2024-01-01

Abstract:Table of key reagents and resources.

Supplementary Table S1 from Lactate Induces Tumor Progression Via LAR Motif-Dependent Yin-Yang 1 Degradation

Supplementary Table S2 from Lactate Induces Tumor Progression Via LAR Motif-Dependent Yin-Yang 1 Degradation

Supplementary Tables from LIMS1 Promotes Pancreatic Cancer Cell Survival under Oxygen–Glucose Deprivation Conditions by Enhancing HIF1A Protein Translation

Supplementary Figure S5 from Lactate Induces Tumor Progression Via LAR Motif-Dependent Yin-Yang 1 Degradation

Supplementary Figure S6 from Lactate Induces Tumor Progression Via LAR Motif-Dependent Yin-Yang 1 Degradation

Supplementary Figure S2 from Lactate Induces Tumor Progression Via LAR Motif-Dependent Yin-Yang 1 Degradation

Supplementary Table S1 from Distinct Regulation of ASCL1 by the Cell Cycle and Chemotherapy in Small Cell Lung Cancer

Supplementary Table 2 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Additional File 9 of Carbohydrates and Ginsenosides in Shenmai Injection Jointly Improve Hematopoietic Function During Chemotherapy-Induced Myelosuppression in Mice

Lactate induces tumor progression via LAR motif-dependent Yin-Yang 1 degradation

Supplementary Table 1 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis

Supplemental Table S3 from Histone Deacetylase HDAC8 Promotes Insulin Resistance and Β-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma

Supplementary Methods, Figures 1-9, Tables 2-6 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes Β-Catenin–dependent Hepatocarcinogenesis

Supplementary Table 7 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes Β-Catenin–dependent Hepatocarcinogenesis

Supplementary Table 1 from RAGE Expression in Tumor-Associated Macrophages Promotes Angiogenesis in Glioma

Table S1 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Supplemental Table S1 from Histone Deacetylase HDAC8 Promotes Insulin Resistance and Β-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma

Table S2 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Supplementary Table 1 from CD155T/TIGIT Signaling Regulates CD8<sup>+</sup> T-cell Metabolism and Promotes Tumor Progression in Human Gastric Cancer

Supplementary Tables from MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway

Supplementary Table 6 from <i>linc00869</i> Promotes Hepatocellular Carcinoma Metastasis Via Protrusion Formation

Supplementary Table S1 from Lactate Induces Tumor Progression Via LAR Motif-Dependent Yin-Yang 1 Degradation

Supplementary Table S2 from Lactate Induces Tumor Progression Via LAR Motif-Dependent Yin-Yang 1 Degradation

Supplementary Tables from LIMS1 Promotes Pancreatic Cancer Cell Survival under Oxygen–Glucose Deprivation Conditions by Enhancing HIF1A Protein Translation

Supplementary Figure S5 from Lactate Induces Tumor Progression Via LAR Motif-Dependent Yin-Yang 1 Degradation

Supplementary Figure S6 from Lactate Induces Tumor Progression Via LAR Motif-Dependent Yin-Yang 1 Degradation

Supplementary Figure S2 from Lactate Induces Tumor Progression Via LAR Motif-Dependent Yin-Yang 1 Degradation

Supplementary Table S1 from Distinct Regulation of ASCL1 by the Cell Cycle and Chemotherapy in Small Cell Lung Cancer

Supplementary Table 2 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Additional File 9 of Carbohydrates and Ginsenosides in Shenmai Injection Jointly Improve Hematopoietic Function During Chemotherapy-Induced Myelosuppression in Mice

Lactate induces tumor progression via LAR motif-dependent Yin-Yang 1 degradation

Supplementary Table 1 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis

Supplemental Table S3 from Histone Deacetylase HDAC8 Promotes Insulin Resistance and Β-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma

Supplementary Methods, Figures 1-9, Tables 2-6 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes Β-Catenin–dependent Hepatocarcinogenesis

Supplementary Table 7 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes Β-Catenin–dependent Hepatocarcinogenesis

Supplementary Table 1 from RAGE Expression in Tumor-Associated Macrophages Promotes Angiogenesis in Glioma

Table S1 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Supplemental Table S1 from Histone Deacetylase HDAC8 Promotes Insulin Resistance and Β-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma

Table S2 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Supplementary Table 1 from CD155T/TIGIT Signaling Regulates CD8&lt;sup&gt;+&lt;/sup&gt; T-cell Metabolism and Promotes Tumor Progression in Human Gastric Cancer

Supplementary Tables from MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway

Supplementary Table 6 from &lt;i&gt;linc00869&lt;/i&gt; Promotes Hepatocellular Carcinoma Metastasis Via Protrusion Formation

Supplementary Table 1 from CD155T/TIGIT Signaling Regulates CD8<sup>+</sup> T-cell Metabolism and Promotes Tumor Progression in Human Gastric Cancer

Supplementary Table 6 from <i>linc00869</i> Promotes Hepatocellular Carcinoma Metastasis Via Protrusion Formation